Fonseca Biosciences has launched XTORO (finafloxacin otic suspension) 0.3% in [...]

FORE Biotherapeutics has completed target enrolment in the primary central [...]

Compass Pathways has reported positive six-month results from its second [...]

Healome Therapeutics has raised £2 million in seed funding to [...]

Abivax has reported positive topline results from Part 2 of [...]

Telix Pharmaceuticals has received FDA agreement on the protocol and [...]

Cereno Scientific has reported encouraging 12-month safety and clinical observations [...]

BridgeBio has published results from its pivotal Phase 3 Propel [...]

GlobalData has identified Takeda’s oveporexton FDA decision as one of [...]

Grifols has launched Fesilty in the USA, making the fibrinogen [...]